NEW DELHI – There has been mixed reaction – by and large welcoming – among India's pharmaceutical and biotechnology industry to a proposal by the Indian government to simplify corporate tax laws and end a "sunset" clause for companies that receive tax benefits as part of setting up in special economic zones (SEZ).